Valsartan inhibits NPC cell line CNE-2 proliferation and invasion and promotes its sensitivity to radiation

European Journal of Cancer Prevention

Volumn 18, Issue 6, 2009, Pages 510-517

  Wang, Qiong ^a   Zhao, Wei ^a   Wu, Gang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Apoptosis; Invasion; Nasopharyngeal neoplasm; Radiosensitization reagent; Vascular endothelial growth factor

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; VALSARTAN; VASCULOTROPIN;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GAMMA RADIATION; HUMAN; HUMAN CELL; IN VITRO STUDY; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RADIOSENSITIVITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; APOPTOSIS; BLOTTING, WESTERN; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; COBALT RADIOISOTOPES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GAMMA RAYS; HUMANS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM INVASIVENESS; RADIATION TOLERANCE; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, ANGIOTENSIN, TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TETRAZOLES; TUMOR CELLS, CULTURED; VALINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 70349835755     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32832f9c00     Document Type: Article

References (32)

1. Arrieta O, Guevara P, Escobar E, García-Navarrete R, Pineda B, Sotelo J (2005). Blockage of angiotensin II type 1 receptor decreases the synthesis of growth factors and induces apoptosis in C6 cultured cells and C6 rat glioma. Br J Cancer 92:1247-1252.
2. Chua CC, Hamdy RC, Chua BH (1998). Up regulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells. Biochim Biophys Acta 1401:187-194.
3. Chua DT, Ma J, Sham JS, Mai HQ, Choy DT, Hong MH, et al. (2006). Improvement of survival after addition of induction chemotherapy to radiotherapy in patients with early-stage nasopharyngeal carcinoma: subgroup analysis of two phase III trials. Int J Radiat Oncol Biol Phys 65:1300-1306.
4. Egami K, Murohara T, Shimada T, Sasaki K, Shintani S, Sugaya T, et al. (2003). Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. J Clin Invest 112:67-75.
5. Fujimoto Y, Sasaki T, Tsuchida A, Chayama K (2001). Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonist. FEBS Lett 495:197-200.
6. Guang WH, Sunagawa M, Jie EL, Shimada S, Gang Z, Tokeshi Y, et al. (2000). The relationship between microvessel density, the expression of vascular endothelial growth factor (VEGF), and the extension of nasopharyngeal carcinoma. Laryngoscope 110:2066-2069.
7. Guo X, Cao SM, Hong MH, Zhang CQ, Han AJ, Xiang YQ, et al. (2004). Clinical value of vascular endothelial growth factor detection in forecasting distant metastasis risk of nasopharyngeal carcinoma. Ai Zheng 23:1171-1175.
8. Hashimoto G, Inoki I, Fujii Y, Aoki T, Ikeda E, Okada Y (2002). Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165. J Biol Chem 277:36288-36295.
9. Helin K, Stoll M, Meffert S, Stroth U, Unger T (1997). The role of angiotensin receptors in cardiovascular diseases. Ann Med 29:23-29.
10. Jiang WZ, Liao YP, Zhao SP, Wu HJ (2006). Expression clinical significance of nm23-H1 and vessel endothelium growth factor protein in nasopharyngeal carcinoma. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 41:200-204.
11. Juillerat-Jeanneret L, Celerier J, Chapuis Bernasconi C, Nguyen G, Wostl W, Maerki HP, et al. (2004). Renin and angiotensinogen expression and functions in growth and apoptosis of human glioblastoma. Br J Cancer 90:1059-1068.
12. Kamath L, Meydani A, Foss F, Kuliopulos A (2001). Signaling from proteaseactivated receptor-1 inhibits migration and invasion of breast cancer cells. Cancer Res 61:5933-5940.
13. Kikkawa F, Mizuno M, Shibata K, Kajiyama H, Morita T, Ino K, et al. (2004). Activation of invasiveness of cervical carcinoma cells by angiotensin II. Am J Obstet Gynecol 190:1258-1263.
14. Koh WP, Yuan JM, Van Den Berg D, Lee HP, Yu MC (2005). Polymorphisms in angiotensin II type 1 receptor and angiotensin I-converting enzyme genes and breast cancer risk among Chinese women in Singapore. Carcinogenesis 26:459-464.
15. Krishna SM, James S, Balaram P (2006). Expression of VEGF as prognosticator in primary nasopharyngeal cancer and its relation to EBV status. Virus Res 115:85-90.
16. Meng Y, Jin Y (2002). Status and advances of gene therapy combined with radiotherapy in malignant tumor. J Oncol 8:63-65.
17. Muscella A, Greco S, Elia MG, Storelli C, Marsigliante S (2002). Angiotensin II stimulation of Na+/K+ ATPase activity and cell growth by calcium-independent pathway in MCF-7 breast cancer cells. J Endocrinol 173:315-323.
18. Nadal JA, Scicli GM, Carbini LA, Scicli AG (2002). Angiotensin II stimulates migration of retinal microvascular pericytes: involvement of TGF-h and PDGF-BB. Am J Physiol Heart Circ Physiol 282:H739-H748.
19. Pupilli C, Lasagni L, Romagnani P, Bellini F, Mannelli M, Misciglia N, et al. (1999). Angiotensin II stimulates the synthesis and secretion of vascular permeability factor/vascular endothelial growth factor in human mesangial cells. J Am Soc Nephrol 10:245-255.
20. Rousseau S, Houle F, Landry J, Huot J (1997). p38MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene 15:2169-2177.
21. Sha D, He YJ (2006). Expression and clinical significance of VEGF and its receptors Flt-1 and KDR in nasopharyngeal carcinoma. Ai Zheng 25:229-234.
22. Suganuma T, Ino K, Shibata K, Kajiyama H, Nagasaka T, Mizutani S, et al. (2005). Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination. Clin Cancer Res 11:2686-2694.
23. Touyz RM, Deng LY, He G, Wu XH, Schiffrin EL (2001). Angiotensin II stimulates DNA and protein synthesis in vascular smooth muscle cells from human arteries: role of extracellular signal-regulated kinases. J Hypertens 17:907-916.
24. Uemura H, Ishiguro H, Nakaigawa N, Nagashima Y, Miyoshi Y, Fujinami K, et al. (2003). Angiotensin II receptor blocker shows antiproliferative activity in prostate cancer cells: a possibility of tyrosine kinase inhibitor of growth factor. Mol Cancer Ther 2:1139-1147.
25. Wakisaka N,Wen QH, Yoshizaki T, Nishimura T, Furukawa M, Kawahara E, et al. (1999). Association of vascular endothelial growth factor expression with angiogenesis and lymph node metastasis in nasopharyngeal carcinoma. Laryngoscope 109:810-814.
26. Wang Y, Kong W, Yue J, Sun D, Li W, Yao Q, et al. (2006). Vascular endothelial growth factor165-regulated nasopharyngeal carcinoma cell lines invasion and migration involve expression and activation of matrix metalloproteinase-2. J Huazhong Univ Sci Technolog Med Sci 26:621-624.
27. Williams B, Baker AQ, Gallacher B, Lodwick D (1999). Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells. Hypertension 25:913-917.
28. Xia J, Xia K, Feng Y, Tang A, Tang Y, Wu L, et al. (2007). The combination of suicide gene therapy and radiation enhances the killing of nasopharyngeal carcinoma xenographs. J Radiat Res 45:281-289.
29. Yang HF, Tang WP (2003). Vascular endothelial growth factor gene expression in nasopharyngeal carcinoma cell line induced by hypoxia in vitro. Ai Zheng 22:160-163.
30. YeWJ, Min HQ, Cao XP, Chen KT, Hou JH, Li Y (2006). Correlations of biomolecular markers, such as P53 protein and vascular endothelial growth factor, to radiosensitivity of nasopharyngeal carcinoma. Ai Zheng 25:1168-1172.
31. Yong-Sheng KE, Yue-Yu TAO, Hao Y, Guo-Hua YU (2003). Effects of valsartan with or without benazepril on blood pressure, angiotensin II, and endoxin in patients with essential hypertension. Acta Pharmacol Sin 24:337-341.
32. Zhao SP, Wang CL (2003). Expression and clinical significance of vascular endothelial factor in nasopharyngeal carcinoma. Hunan Yi Ke Da Xue Xue Bao 28:114-116.